The Minimum Data Set Agitated and Reactive Behavior Scale: Measuring Behaviors in Nursing Home Residents With Dementia.
Aged, 80 and over
Aggression
Anti-Anxiety Agents
/ therapeutic use
Antidepressive Agents
/ therapeutic use
Antipsychotic Agents
/ therapeutic use
Cross-Sectional Studies
Dementia
/ drug therapy
Drug Utilization
/ statistics & numerical data
Female
Geriatric Assessment
Humans
Male
Mental Disorders
/ epidemiology
Nursing Homes
Psychomotor Agitation
Reproducibility of Results
Severity of Illness Index
United States
/ epidemiology
Dementia
behaviors
measurement
nursing home
Journal
Journal of the American Medical Directors Association
ISSN: 1538-9375
Titre abrégé: J Am Med Dir Assoc
Pays: United States
ID NLM: 100893243
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
17
06
2019
revised:
24
08
2019
accepted:
30
08
2019
pubmed:
5
11
2019
medline:
11
11
2020
entrez:
4
11
2019
Statut:
ppublish
Résumé
Interventions aimed at managing agitated and aggressive behaviors in dementia without the use of antipsychotics are currently being tested in nursing homes (NHs). Researchers and clinicians require a measure that can capture the severity of residents' behaviors. We test the internal consistency and construct validity of the Agitated and Reactive Behavior Scale (ARBS), a measure created using data from mandatory NH assessments. Cross-sectional. The 2016 national sample of 15,326 Centers for Medicare and Medicaid Services-certified NHs. The analytic sample included 489,854 new admissions and 765,367 long-stay residents (at least 90 days in NH). All participants have a dementia diagnosis. Minimum Data Set (MDS), version 3.0. The ARBS is a composite measure of (1) physical behavioral symptoms directed at other people; (2) verbal behavioral symptoms directed at other people; (3) other behavioral symptoms not directed at other people; and (4) rejection of care. Variables used to establish construct validity included degree of cognitive impairment, use of medications for managing agitation and aggression, and co-occurring conditions associated with agitated and aggressive behaviors (eg, schizophrenia, depression, or delirium). This report has 3 important findings: (1) the ARBS score has borderline-adequate internal consistency (α = .64-.71) in the national population NH residents with dementia; (2) only 18% of new admissions and 21% of long-stay residents with dementia evidence any agitated or aggressive behaviors in the last week, as rated in the MDS assessment; and (3) the ARBS demonstrates good construct validity; it increases with cognitive impairment, treatment with relevant medications, and co-occurring psychiatric conditions and symptoms. Nationally available MDS data may significantly underestimate the prevalence of agitated and aggressive behaviors among NH residents with dementia. Researchers conducting pragmatic trials of non-pharmaceutical interventions to manage behaviors in NH residents with dementia should consider the likely underdetection of these behaviors in the available MDS data.
Identifiants
pubmed: 31678075
pii: S1525-8610(19)30647-4
doi: 10.1016/j.jamda.2019.08.030
pmc: PMC7008595
mid: NIHMS1542178
pii:
doi:
Substances chimiques
Anti-Anxiety Agents
0
Antidepressive Agents
0
Antipsychotic Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1548-1552Subventions
Organisme : HSRD VA
ID : IK2 HX001775
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG057451
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG027296
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG057451
Pays : United States
Organisme : AHRQ HHS
ID : T32 HS000011
Pays : United States
Informations de copyright
Copyright © 2019 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.
Références
JAMA. 2013 Feb 6;309(5):440-2
pubmed: 23385262
Am J Geriatr Psychiatry. 2005 Nov;13(11):991-8
pubmed: 16286443
Med Care. 2017 Sep;55(9):e68-e72
pubmed: 25763665
Am J Alzheimers Dis Other Demen. 2002 Jul-Aug;17(4):249-53
pubmed: 12184515
Clin Gerontol. 2019 May-Jun;42(3):297-301
pubmed: 29206577
J Psychiatr Res. 2008 Nov;43(1):64-9
pubmed: 18394647
J Am Med Dir Assoc. 2010 Feb;11(2):120-7
pubmed: 20142067
JAMA Intern Med. 2018 May 1;178(5):640-647
pubmed: 29550856
J Gerontol. 1989 May;44(3):M77-84
pubmed: 2715584
J Geriatr Psychiatry Neurol. 2011 Jun;24(2):67-72
pubmed: 21460341
Ann Intern Med. 2007 Jun 5;146(11):775-86
pubmed: 17548409
J Am Geriatr Soc. 2007 Jul;55(7):1099-105
pubmed: 17608886
J Gen Intern Med. 2013 May;28(5):660-7
pubmed: 23225256
Gerontologist. 2000 Dec;40(6):663-72
pubmed: 11131083
Arch Intern Med. 2010 Jan 11;170(1):96-103
pubmed: 20065205
J Am Med Dir Assoc. 2008 May;9(4):244-50
pubmed: 18457799
J Pain Symptom Manage. 2004 Apr;27(4):343-51
pubmed: 15050662
Int J Med Educ. 2011 Jun 27;2:53-55
pubmed: 28029643
J Am Geriatr Soc. 2008 Dec;56(12):2298-303
pubmed: 19093929
JAMA Psychiatry. 2015 May;72(5):438-45
pubmed: 25786075
J Am Med Dir Assoc. 2018 Apr;19(4):323-327
pubmed: 29396185
J Geriatr Psychiatry Neurol. 2007 Mar;20(1):41-9
pubmed: 17341770
J Am Med Dir Assoc. 2008 May;9(4):211-2
pubmed: 18457794
BMC Geriatr. 2013 Feb 11;13:14
pubmed: 23399452
Vital Health Stat 3. 2016 Feb;(38):x-xii; 1-105
pubmed: 27023287
J Am Med Dir Assoc. 2018 Dec;19(12):1035-1038
pubmed: 30197272
JAMA. 2017 Nov 14;318(18):1829-1830
pubmed: 29136436